Detalhe da pesquisa
1.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
2.
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
Vaccine
; 42(10): 2695-2706, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494412
3.
MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaques.
NPJ Vaccines
; 9(1): 47, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413593
4.
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication.
Sci Rep
; 13(1): 5162, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997583
5.
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.
Front Immunol
; 14: 1215302, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37727795
6.
A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.
Front Immunol
; 13: 841471, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35774800
7.
Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels.
Vaccines (Basel)
; 10(8)2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36016151
8.
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.
Front Immunol
; 13: 857440, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35479095
9.
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
Vaccine
; 39(22): 3067-3080, 2021 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077299
10.
A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Front Immunol
; 11: 598847, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542715
11.
Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Vaccine
; 38(4): 769-778, 2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718901
12.
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
NPJ Vaccines
; 5(1): 112, 2020 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335092
13.
Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
Front Immunol
; 9: 1756, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30116244
14.
Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
Vaccine
; 36(34): 5194-5203, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30037666
15.
A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responses.
Vaccine
; 36(18): 2427-2434, 2018 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599088
16.
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
PLoS One
; 13(4): e0196546, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29689118
17.
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
PLoS One
; 13(2): e0192312, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462200
18.
Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.
Vaccine
; 27(40): 5496-504, 2009 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19632316
19.
Cortisol metabolism by 11 beta-hydroxysteroid dehydrogenase as a novel target in the treatment of inflammation- or immune-mediated bone loss: comment on the article by Makrygiannakis et al.
Arthritis Rheum
; 56(1): 387-8, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17195247